Acute and Chronic Effects of Dynamic Apnea in Healthy Untrained Subjects
- Conditions
- Apnea
- Interventions
- Other: Program of training with exercises including apneaOther: Program of training with exercises without apnea
- Registration Number
- NCT03095677
- Lead Sponsor
- Centre Hospitalier Régional d'Orléans
- Brief Summary
The inclusion of short periods of apnea (several seconds) during exercise (i.e. dynamic apnea) induces a significant decrease in blood oxygenation and muscle tissue. To date, the immediate effects ("acute apnea") of this decrease in the quantity of oxygen available at the muscle and brain level are poorly understood. Moreover, a physical training during which these short periods of apnea ("chronic apnea") would be included could lead to physiological adaptations and to improvement in physical performance similar to those obtained during altitude training.
The purpose of this study is to evaluate the effects of acute dynamic apnea on metabolism.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Male
- Target Recruitment
- 25
- The cutaneous thickness at the vastus lateralis level lower than 1.5 cm to obtain the reliable muscle oxygenation measurement
- Subjects will have to sign the inform consent before the beginning of the study
- Contraindications to regular physical exercise practice
- To practice an endurance sport more than 1h/week
- Regular practice of apnea
- Chronic use of cannabis and/or alcohol
- Cardiac or metabolic pathology
- Asthma and/or bronchodilatator treatment
- ECG abnormality at rest
- Regular consumption of tobacco
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Apnea Group (GApn) Program of training with exercises including apnea Program of training with exercises including apneas Control Group (GC) Program of training with exercises without apnea Program of training with exercises without apnea
- Primary Outcome Measures
Name Time Method Measurement of arterial saturation in dioxygen 12 weeks Measurement by ear blood micro-sample
Spectometry to measure hemoglobin rate 3 weeks Measurement of oxygenation
Wingate test to measure maximum consumption of dioxygen 3 weeks Measurement of aerobic performance
Measurement of hormonal markers 12 weeks Measurement of Dehydroepiandrostenedione (DHEA)
Jaeger debimeter system to measure of peak oxygen 12 weeks Measurement of oxygen consumption,
Spectometry to measure hemoglobin 12 weeks Measurement of oxygenation
- Secondary Outcome Measures
Name Time Method Cardiac frequency 12 weeks measurement with a 12 lead - Electrocardiogramm
Borg scale to measure penibility of the effort week 12
Trial Locations
- Locations (1)
CHR d'Orléans
🇫🇷Orléans, France